Evidence for an effect of ACE inhibitors on cancer cachexia

Journal of Cachexia, Sarcopenia and Muscle - Tập 3 - Trang 139-139 - 2012
Nancy Schanze1,2, Jochen Springer1,2,3
1Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany
2Center for Cardiovascular Research, Charite Medical School, Berlin, Germany
3Norwich Medical School, University of East Anglia, Norwich, UK

Tài liệu tham khảo

Trobec K, von Haehling S, Anker SD, Lainscak M. Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle. 2011;2:191–200. Epub 2011 Oct PubMed PMID: 22207907; PubMed Central PMCID: PMC3222822. http://www.apmhealtheurope.com/print_story.php?numero=L1135 http://www.biopharmaceutiques.com/fr/tables/clinical_studies_316.html Sanders PM, Russell ST, Tisdale MJ. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. Br J Cancer. 2005;93:425–34. von Haehling S, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010;1:7–8.